rs1061122
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000361147.8(KCNN3):c.-102G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.22 in 1,612,166 control chromosomes in the GnomAD database, including 42,768 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.27 ( 6422 hom., cov: 33)
Exomes 𝑓: 0.21 ( 36346 hom. )
Consequence
KCNN3
ENST00000361147.8 5_prime_UTR
ENST00000361147.8 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -3.39
Publications
13 publications found
Genes affected
KCNN3 (HGNC:6292): (potassium calcium-activated channel subfamily N member 3) Action potentials in vertebrate neurons are followed by an afterhyperpolarization (AHP) that may persist for several seconds and may have profound consequences for the firing pattern of the neuron. Each component of the AHP is kinetically distinct and is mediated by different calcium-activated potassium channels. This gene belongs to the KCNN family of potassium channels. It encodes an integral membrane protein that forms a voltage-independent calcium-activated channel, which is thought to regulate neuronal excitability by contributing to the slow component of synaptic AHP. This gene contains two CAG repeat regions in the coding sequence. It was thought that expansion of one or both of these repeats could lead to an increased susceptibility to schizophrenia or bipolar disorder, but studies indicate that this is probably not the case. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
KCNN3 Gene-Disease associations (from GenCC):
- Zimmermann-Laband syndrome 3Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Zimmermann-Laband syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- schizophreniaInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.424 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNN3 | NM_002249.6 | c.933+9218G>A | intron_variant | Intron 1 of 7 | ENST00000271915.9 | NP_002240.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KCNN3 | ENST00000361147.8 | c.-102G>A | 5_prime_UTR_variant | Exon 1 of 8 | 1 | ENSP00000354764.4 | ||||
| KCNN3 | ENST00000271915.9 | c.933+9218G>A | intron_variant | Intron 1 of 7 | 1 | NM_002249.6 | ENSP00000271915.3 | |||
| KCNN3 | ENST00000358505.2 | c.-7+8135G>A | intron_variant | Intron 1 of 7 | 1 | ENSP00000351295.2 | ||||
| KCNN3 | ENST00000618040.4 | c.933+9218G>A | intron_variant | Intron 1 of 8 | 5 | ENSP00000481848.1 |
Frequencies
GnomAD3 genomes AF: 0.268 AC: 40720AN: 152052Hom.: 6418 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
40720
AN:
152052
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.214 AC: 313144AN: 1459996Hom.: 36346 Cov.: 32 AF XY: 0.212 AC XY: 153926AN XY: 726312 show subpopulations
GnomAD4 exome
AF:
AC:
313144
AN:
1459996
Hom.:
Cov.:
32
AF XY:
AC XY:
153926
AN XY:
726312
show subpopulations
African (AFR)
AF:
AC:
14593
AN:
33446
American (AMR)
AF:
AC:
6042
AN:
44590
Ashkenazi Jewish (ASJ)
AF:
AC:
6618
AN:
26102
East Asian (EAS)
AF:
AC:
219
AN:
39674
South Asian (SAS)
AF:
AC:
11376
AN:
86130
European-Finnish (FIN)
AF:
AC:
10513
AN:
53178
Middle Eastern (MID)
AF:
AC:
1387
AN:
5754
European-Non Finnish (NFE)
AF:
AC:
249463
AN:
1110792
Other (OTH)
AF:
AC:
12933
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
12988
25976
38964
51952
64940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8390
16780
25170
33560
41950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.268 AC: 40745AN: 152170Hom.: 6422 Cov.: 33 AF XY: 0.259 AC XY: 19252AN XY: 74422 show subpopulations
GnomAD4 genome
AF:
AC:
40745
AN:
152170
Hom.:
Cov.:
33
AF XY:
AC XY:
19252
AN XY:
74422
show subpopulations
African (AFR)
AF:
AC:
17816
AN:
41478
American (AMR)
AF:
AC:
2917
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
927
AN:
3470
East Asian (EAS)
AF:
AC:
50
AN:
5190
South Asian (SAS)
AF:
AC:
614
AN:
4830
European-Finnish (FIN)
AF:
AC:
2105
AN:
10610
Middle Eastern (MID)
AF:
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15415
AN:
67972
Other (OTH)
AF:
AC:
504
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1449
2897
4346
5794
7243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
394
788
1182
1576
1970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
251
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.